NCT00024479 Studies of the Natural History of Rheumatic Diseases
| NCT ID | NCT00024479 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
| Condition | Rheumatic Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 7,500 participants |
| Start Date | 2001-10-03 |
| Primary Completion | — |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 7,500 participants in total. It began in 2001-10-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will explore the causes of rheumatic diseases and why many of them affect certain minority communities more severely. Rheumatic diseases may cause joint pain, stiffness or swelling. Some can involve bones, muscles, tendons or ligaments. Some cause abnormalities of the immune system-the body s defense against disease. Some rheumatic diseases are painful or deforming and some can be life threatening. Information obtained from this study will be used to learn about the disparities in rheumatic disease in the minority community and to design further, more targeted, research studies to address this issue. Patients with known or suspected rheumatic disease 18 years of age or older may be eligible for this study. Candidates will undergo a medical history and physical examination to confirm the diagnosis of rheumatic disease and determine what is needed for evaluation and treatment. Participants will receive standard medical care for rheumatic disease and arthritis. No experimental treatments, medications or procedures will be included in this study. Procedures may include routine blood tests for blood chemistries, cell counts, and antibodies commonly found in patients with rheumatic disease; a urine test for proteins and cells; and X-rays and other imaging tests to check for abnormalities in the lungs or other organs. All medical information will be kept confidential. Patients who are found to be eligible for other current NIH research studies will be offered an opportunity to participate in these studies.
Eligibility Criteria
* INCLUSION CRITERIA: Known or suspected rheumatic disease Age greater than or equal to 18 years Willingness and capacity to provide informed consent. EXCLUSION CRITERIA: Patients will be excluded if any of the inclusion criteria cannot be met. Women who are pregnant or breastfeeding at the time of enrollment.
Contact & Investigator
Sarfaraz A Hasni, M.D.
PRINCIPAL INVESTIGATOR
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Frequently Asked Questions
Who can join the NCT00024479 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Rheumatic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00024479 currently recruiting?
Yes, NCT00024479 is actively recruiting participants. Contact the research team at nancy.spencer@nih.gov for enrollment information.
Where is the NCT00024479 trial being conducted?
This trial is being conducted at Bethesda, United States.
Who is sponsoring the NCT00024479 clinical trial?
NCT00024479 is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The principal investigator is Sarfaraz A Hasni, M.D. at National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The trial plans to enroll 7,500 participants.